Luca Sangiorgi

6.3k total citations · 3 hit papers
114 papers, 3.9k citations indexed

About

Luca Sangiorgi is a scholar working on Rheumatology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luca Sangiorgi has authored 114 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 43 papers in Genetics and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luca Sangiorgi's work include Sarcoma Diagnosis and Treatment (36 papers), Bone Tumor Diagnosis and Treatments (36 papers) and Connective tissue disorders research (25 papers). Luca Sangiorgi is often cited by papers focused on Sarcoma Diagnosis and Treatment (36 papers), Bone Tumor Diagnosis and Treatments (36 papers) and Connective tissue disorders research (25 papers). Luca Sangiorgi collaborates with scholars based in Italy, United States and Netherlands. Luca Sangiorgi's co-authors include Piero Picci, Elena Pedrini, Gen Nishimura, Andrea Superti‐Furga, Sheila Unger, Marina Mordenti, James R. Neff, David Sillence, Geert Mortier and Valérie Cormier‐Daire and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Luca Sangiorgi

105 papers receiving 3.8k citations

Hit Papers

Nosology and classification of genetic skeletal disorde... 2015 2026 2018 2022 2019 2015 2020 100 200 300

Peers

Luca Sangiorgi
Ken Omura Japan
Noriaki Ono United States
Michael T. Collins United States
Edward F. McCarthy United States
Rachel I. Gafni United States
Ken Omura Japan
Luca Sangiorgi
Citations per year, relative to Luca Sangiorgi Luca Sangiorgi (= 1×) peers Ken Omura

Countries citing papers authored by Luca Sangiorgi

Since Specialization
Citations

This map shows the geographic impact of Luca Sangiorgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Sangiorgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Sangiorgi more than expected).

Fields of papers citing papers by Luca Sangiorgi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Sangiorgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Sangiorgi. The network helps show where Luca Sangiorgi may publish in the future.

Co-authorship network of co-authors of Luca Sangiorgi

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Sangiorgi. A scholar is included among the top collaborators of Luca Sangiorgi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Sangiorgi. Luca Sangiorgi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedrini, Elena, Morena Tremosini, Dario Cocciadiferro, et al.. (2025). Further Evidence of Early-Onset Osteoporosis and Bone Fractures as a New FGFR2-Related Phenotype. International Journal of Molecular Sciences. 26(9). 4204–4204.
2.
Sangiorgi, Luca, et al.. (2024). Project SATURN– a real-world evidence data collaboration with existing European datasets in Osteogenesis Imperfecta to support future therapies. Orphanet Journal of Rare Diseases. 19(1). 184–184. 1 indexed citations
3.
Bartolotti, Isabella, et al.. (2024). A Novel Pathogenic Large Duplication in EXT1 Identified in a Family with Multiple Osteochondromas. Genes. 15(9). 1169–1169.
5.
Pazzaglia, Laura, Elena Pedrini, Andrea Sambri, et al.. (2024). p53 as a Potential Actionable Target in Myxofibrosarcoma: A Molecular and Pathologic Review of a Single-Institute Series. Laboratory Investigation. 104(8). 102088–102088.
6.
7.
Appelman‐Dijkstra, Natasha M., Maria Luisa Brandi, Roland Chapurlat, et al.. (2024). ERN BOND: The key European network leveraging diagnosis, research, and treatment for rare bone conditions. European Journal of Medical Genetics. 68. 104916–104916. 3 indexed citations
8.
Sangiorgi, Luca, Marina Mordenti, Victoria Wang, et al.. (2024). SATURN: assessing the feasibility of utilising existing registries for real-world evidence data collection to meet patients, regulatory, health technology assessment and payer requirements. Orphanet Journal of Rare Diseases. 19(1). 336–336. 1 indexed citations
9.
Gnoli, Maria, et al.. (2023). Vitamin D and Bone fragility in Individuals with Osteogenesis Imperfecta: A Scoping Review. International Journal of Molecular Sciences. 24(11). 9416–9416. 5 indexed citations
10.
Mordenti, Marina, Morena Tremosini, Manuela Locatelli, et al.. (2023). Cost-effectiveness of bringing a nurse into an Italian genetic day clinic: a before and after study. BMC Health Services Research. 23(1). 1278–1278. 2 indexed citations
11.
Maurizi, Antonio, Ahmed El‐Gazzar, Maria Luisa Brandi, et al.. (2023). High bone mass disorders: New insights from connecting the clinic and the bench. Yearbook of pediatric endocrinology. 2 indexed citations
12.
Collins, Michael T., Gemma Marcucci, Hans‐Joachim Anders, et al.. (2022). Author Correction: Skeletal and extraskeletal disorders of biomineralization. Nature Reviews Endocrinology. 19(1). 62–62. 1 indexed citations
13.
Collins, Michael T., Gemma Marcucci, Hans‐Joachim Anders, et al.. (2022). Skeletal and extraskeletal disorders of biomineralization. Nature Reviews Endocrinology. 18(8). 473–489. 41 indexed citations
14.
Gnoli, Maria, Evelise Brizola, Morena Tremosini, et al.. (2021). COL1-Related Disorders: Case Report and Review of Overlapping Syndromes. Frontiers in Genetics. 12. 640558–640558. 13 indexed citations
15.
Brizola, Evelise, Maria Gnoli, Morena Tremosini, et al.. (2020). Variable clinical expression of Stickler Syndrome: A case report of a novel COL11A1 mutation. Molecular Genetics & Genomic Medicine. 8(9). e1353–e1353. 5 indexed citations
16.
Bergen, Dylan J. M., Antonio Maurizi, Melissa M. Formosa, et al.. (2020). High Bone Mass Disorders: New Insights From Connecting the Clinic and the Bench. Journal of Bone and Mineral Research. 38(2). 229–247. 6 indexed citations
17.
Baldo, Chiara, Alessandra Renieri, Giuseppe Merla, et al.. (2016). The alliance between genetic biobanks and patient organisations: the experience of the telethon network of genetic biobanks. Orphanet Journal of Rare Diseases. 11(1). 142–142. 27 indexed citations
18.
Bonafé, Luisa, Valérie Cormier‐Daire, Christine M Hall, et al.. (2015). Nosology and classification of genetic skeletal disorders: 2015 revision. American Journal of Medical Genetics Part A. 167(12). 2869–2892. 367 indexed citations breakdown →
19.
Swinnen, Freya, Paul Coucke, Anne M. De Paepe, et al.. (2011). Osteogenesis imperfecta: the audiological phenotype lacks correlation with the genotype. Orphanet Journal of Rare Diseases. 6(1). 88–88. 45 indexed citations
20.
Ferrari, Cristina, Tom Böhling, M. S. Benassi, et al.. (1999). Secondary Tumors in Bone Sarcomas After Treatment with Chemotherapy. Cancer Detection and Prevention. 23(5). 368–374. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026